UnitedHealth shares fell 4% on Friday after medical services costs at the healthcare conglomerate were higher than Wall Street expectations for the first time in two years,.
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to.
The past year brought major changes in preventive standards for anxiety, HIV, and RSV along with new guidelines for the treatment of atrial fibrillation.